CAVIN2/SDPR Functioned as a Tumor Suppressor in Lung Adenocarcinoma from Systematic Analysis of Caveolae-Related

Keyun Zhu1, Baichuan Wang2,3, Yingxi Li4

  • 1Department of Thoracic Surgery, Ningbo Medical Centre Lihuili Hospital, Ningbo University, Ningbo, Zhejiang, P. R. China, 315040.

Journal of Cancer
|July 27, 2023
PubMed

Insights

Caveolin and cavin gene expression is reduced in lung cancer. CAVIN2/SDPR acts as a tumor suppressor, inhibiting lung adenocarcinoma cell growth and migration, serving as a promising prognostic biomarker.

Area of Science:

  • Molecular Biology
  • Oncology
  • Genetics

Background:

  • Caveolae-related genes, including caveolins (CAVs) and cavins (CAVINs), are crucial for cellular processes.
  • Their specific roles in lung cancer pathogenesis and clinical significance remain underexplored.

Purpose of the Study:

  • To investigate the expression and clinical significance of CAVs and CAVINs in lung cancer.
  • To elucidate the biological function of CAVIN2/SDPR in lung adenocarcinoma (LUAD).

Main Methods:

  • Analysis of CAV and CAVIN expression at transcriptional and protein levels using public databases (Oncomine, GEPIA, Human Protein Atlas) and patient samples.
  • Prognostic value assessment and molecular interaction analysis (cBioPortal, GeneMANIA, STRING).
  • In vitro experiments to determine the functional role of CAVIN2/SDPR in LUAD cells.

Main Results:

  • CAV1/2 and CAVIN1/2/3 expression were significantly downregulated in LUAD and lung squamous cell carcinoma (LUSC).
  • High expression of CAV1, CAV2, CAV3, CAVIN1, and CAVIN2/SDPR correlated with better prognosis in LUAD, but not LUSC.
  • CAVIN2/SDPR demonstrated independent prognostic value in LUAD and inhibited cell proliferation and migration by inducing apoptosis and S-phase arrest in vitro.

Conclusions:

  • CAVIN2/SDPR functions as a tumor suppressor in LUAD.
  • CAVIN2/SDPR is a potential prognostic biomarker for precision medicine in LUAD.
  • Overexpression of CAVIN2/SDPR inhibits LUAD cell proliferation via apoptosis induction and cell cycle arrest.

Related Concept Videos

Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
4.9K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.1K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.5K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K